Skip to main content

Izervay Interactions

No drug interactions were found for Izervay (avacincaptad pegol ophthalmic). However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.

Izervay (avacincaptad pegol ophthalmic) is in the drug class anti-angiogenic ophthalmic agents. Izervay (avacincaptad pegol ophthalmic) is used to treat the following conditions: Geographic Atrophy, Macular Degeneration.

Izervay disease interactions

There are 3 disease interactions with Izervay (avacincaptad pegol ophthalmic) which include:

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer